Interestingly, it has been recently shown that, upon interferon alpha treatment, EZH2 inhibits ΔNp73α expression in hepato-cellular carcinoma cells (HCC) by direct binding to the p2 promoter [44]. This evidence concerns the gene EZH2 and hepatocellular carcinoma.